Matlaga Brian R, Zagoria Ronald J, Clark Peter E, Hall M Craig
Department of Urology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA.
Curr Urol Rep. 2004 Feb;5(1):39-44. doi: 10.1007/s11934-004-0010-1.
Radiofrequency ablation (RFA) of renal tumors is a relatively new treatment modality in the armamentarium of urologic surgeons. One of the challenges of this technique is attaining a zone of tissue destruction sufficient enough to kill the targeted tumor. Technologic innovations have aided in this effort. The clinical experience with RFA of renal tumors suggests that small, exophytic tumors may be more readily ablated. Although there is much optimism with regard to this technology, further study is required to better define the oncologic efficacy and refine proper patient selection.
肾肿瘤的射频消融术(RFA)是泌尿外科医生治疗手段中的一种相对较新的方法。该技术的挑战之一是要获得足够大的组织破坏区域以杀死目标肿瘤。技术创新有助于实现这一目标。肾肿瘤射频消融术的临床经验表明,小的、外生性肿瘤可能更容易被消融。尽管人们对这项技术充满乐观,但仍需要进一步研究以更好地确定其肿瘤学疗效并优化合适的患者选择。